Research ArticleArticle
Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study
Aladdin J. Mohammad, Martin Englund, Carl Turesson, Gunnar Tomasson and Peter A. Merkel
The Journal of Rheumatology November 2016, jrheum.160249; DOI: https://doi.org/10.3899/jrheum.160249
Aladdin J. Mohammad
From the Department of Clinical Sciences, Section of Rheumatology, Lund University; Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland. Supported by research grants from The Faculty of Medicine, Lund University, Governmental Funding of Clinical Research within National Health Service, and the Swedish Rheumatism Association (Reumatikerförbundet). A.J. Mohammad, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University, and the Vasculitis and Lupus Clinic, Addenbrooke’s Hospital; M. Englund, MD, PhD, Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; C. Turesson, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University; G. Tomasson, MD, Department of Public Health Sciences, University of Iceland; P.A. Merkel, MD, MPH, Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. A.J. Mohammad, Department of Clinical Sciences, Rheumatology, Lund University, S-221 85, Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication September 22, 2016.
Martin Englund
From the Department of Clinical Sciences, Section of Rheumatology, Lund University; Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland. Supported by research grants from The Faculty of Medicine, Lund University, Governmental Funding of Clinical Research within National Health Service, and the Swedish Rheumatism Association (Reumatikerförbundet). A.J. Mohammad, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University, and the Vasculitis and Lupus Clinic, Addenbrooke’s Hospital; M. Englund, MD, PhD, Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; C. Turesson, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University; G. Tomasson, MD, Department of Public Health Sciences, University of Iceland; P.A. Merkel, MD, MPH, Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. A.J. Mohammad, Department of Clinical Sciences, Rheumatology, Lund University, S-221 85, Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication September 22, 2016.
Carl Turesson
From the Department of Clinical Sciences, Section of Rheumatology, Lund University; Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland. Supported by research grants from The Faculty of Medicine, Lund University, Governmental Funding of Clinical Research within National Health Service, and the Swedish Rheumatism Association (Reumatikerförbundet). A.J. Mohammad, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University, and the Vasculitis and Lupus Clinic, Addenbrooke’s Hospital; M. Englund, MD, PhD, Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; C. Turesson, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University; G. Tomasson, MD, Department of Public Health Sciences, University of Iceland; P.A. Merkel, MD, MPH, Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. A.J. Mohammad, Department of Clinical Sciences, Rheumatology, Lund University, S-221 85, Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication September 22, 2016.
Gunnar Tomasson
From the Department of Clinical Sciences, Section of Rheumatology, Lund University; Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland. Supported by research grants from The Faculty of Medicine, Lund University, Governmental Funding of Clinical Research within National Health Service, and the Swedish Rheumatism Association (Reumatikerförbundet). A.J. Mohammad, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University, and the Vasculitis and Lupus Clinic, Addenbrooke’s Hospital; M. Englund, MD, PhD, Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; C. Turesson, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University; G. Tomasson, MD, Department of Public Health Sciences, University of Iceland; P.A. Merkel, MD, MPH, Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. A.J. Mohammad, Department of Clinical Sciences, Rheumatology, Lund University, S-221 85, Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication September 22, 2016.
Peter A. Merkel
From the Department of Clinical Sciences, Section of Rheumatology, Lund University; Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK; Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts; Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Public Health Sciences, University of Iceland, Reykjavik, Iceland. Supported by research grants from The Faculty of Medicine, Lund University, Governmental Funding of Clinical Research within National Health Service, and the Swedish Rheumatism Association (Reumatikerförbundet). A.J. Mohammad, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University, and the Vasculitis and Lupus Clinic, Addenbrooke’s Hospital; M. Englund, MD, PhD, Clinical Epidemiology Unit, Orthopedics, Clinical Sciences Lund, Lund University, and the Clinical Epidemiology Research and Training Unit, Boston University School of Medicine; C. Turesson, MD, PhD, Department of Clinical Sciences, Section of Rheumatology, Lund University; G. Tomasson, MD, Department of Public Health Sciences, University of Iceland; P.A. Merkel, MD, MPH, Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania. Address correspondence to Dr. A.J. Mohammad, Department of Clinical Sciences, Rheumatology, Lund University, S-221 85, Lund, Sweden. E-mail: Aladdin.mohammad@med.lu.se. Accepted for publication September 22, 2016.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study
Aladdin J. Mohammad, Martin Englund, Carl Turesson, Gunnar Tomasson, Peter A. Merkel
The Journal of Rheumatology Nov 2016, jrheum.160249; DOI: 10.3899/jrheum.160249